Wyndham Hotels & Resorts (WH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
25 Mar, 2026Executive summary
The 2026 annual meeting is scheduled for May 14, 2026, with voting on director elections, executive compensation, auditor ratification, and a shareholder proposal on written consent rights.
2025 saw strong operational performance: 4% organic system-wide room growth, record signings, and a 3% increase in the development pipeline to 259,000 rooms.
Financial highlights for 2025 include $193M net income, $353M adjusted net income, $718M adjusted EBITDA, and $433M adjusted free cash flow.
$393M was returned to shareholders in 2025 via $127M in dividends and $266M in stock repurchases.
The company emphasizes resilience, targeted investments, and technology initiatives, including AI-driven booking and guest engagement.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of nine directors, (2) advisory approval of executive compensation, (3) ratification of Deloitte as auditor, and (4) a shareholder proposal to allow action by written consent.
The board recommends voting FOR proposals 1–3 and AGAINST proposal 4.
The board opposes the written consent proposal, citing robust engagement and governance practices.
Board of directors and corporate governance
The board consists of nine directors, seven of whom are independent; all directors stand for annual election.
Board committees include Audit, Compensation, Corporate Governance, and Executive, all with independent members.
The board separates the roles of Chair and CEO and maintains an independent Lead Director.
Directors are selected for diverse skills in hospitality, finance, M&A, international business, and sustainability.
Stockholder engagement reached 75% of outstanding shares in 2025.
Latest events from Wyndham Hotels & Resorts
- Annual meeting to vote on directors, pay, auditor, and written consent proposal.WH
Proxy filing25 Mar 2026 - Record room growth, resilient earnings, and strong capital returns despite RevPAR headwinds.WH
Q4 202519 Feb 2026 - Q2 saw 4% room growth, 22% higher adjusted EPS, and record pipeline expansion.WH
Q2 20242 Feb 2026 - Q3 delivered 4% room growth, $208M EBITDA, record pipeline, and raised 2024 guidance.WH
Q3 202418 Jan 2026 - Record system growth, strong earnings, and new initiatives drive a positive 2025 outlook.WH
Q4 202429 Dec 2025 - Record growth, strong financials, and robust governance drive positive outlook for 2025.WH
Proxy Filing1 Dec 2025 - Director elections, executive pay, and auditor ratification headline the annual meeting agenda.WH
Proxy Filing1 Dec 2025 - Record room and pipeline growth, but 2025 guidance lowered on RevPAR softness.WH
Q1 20251 Dec 2025 - System and pipeline growth offset RevPAR declines, driving higher earnings and strong cash returns.WH
Q3 202524 Oct 2025